Publication

Byline

Location

FDA flags rare vision-loss risk with GLP-1 drugs; doctors say patients need not panic

New Delhi, Nov. 11 -- The US Food and Drug Administration (FDA) has asked makers of all GLP-1 receptor agonist medicines to add a warning to their labels about a possible link to a rare but serious ey... और पढ़ें


Delhi pollution: Doctors advise people to leave city temporarily, say current measures inadequate

New Delhi, Nov. 10 -- With Delhi reeling under severe air pollution, doctors have advised people, who have the option, to leave the city for a few days until air quality improves. Dr Rajesh Chawla, s... और पढ़ें


Uttarakhand drug plant continues functioning despite CDSCO recommended shutdown

New Delhi, Nov. 5 -- Months after a joint inspection recommended an immediate halt to all manufacturing at a pharmaceutical plant in Uttarakhand, there is no record that anyone acted on it and the com... और पढ़ें


Cipla tops drug overcharging dues with Rs.3,576 crore; J&J, Ranbaxy among top five

New Delhi, Nov. 2 -- For more than four decades, India's drug price regulator has been trying to recover money from pharmaceutical companies that charged patients more than the prices allowed under th... और पढ़ें


Fair price in times of sickness

New Delhi, Nov. 2 -- Meeta Singh, 42, who works at a salon in Delhi, was alarmed when a large private hospital quoted around Rs.1 lakh for a laparoscopic surgery for gallbladder removal, without a bre... और पढ़ें


For years, some cancer drugs cost up to 15 times their new price

New Delhi, Oct. 29 -- Before the government capped trade margins, a patient buying some anti-cancer drugs in India could have been paying ten or even fifteen times from what the same medicine they wil... और पढ़ें


Patented, single source cancer drug prices remain unchanged under 30% margin cap, NPPA data shows

New Delhi, Oct. 29 -- Prices of almost all single-source cancer drug entries on the government's revised price list remain unchanged despite the Centre's decision to cap trade margins at 30 per cent, ... और पढ़ें


Cancer drug price cap: Despite steepest cuts on generics, biosimilars, most patented, single-brand drugs keep their prices

New Delhi, Oct. 28 -- A revised drug price list published by the National Pharmaceutical Pricing Authority (NPPA) shows how the government's 30 per cent cap on trade margins for cancer drugs is playin... और पढ़ें


Healthcare leaders question govt treatment rates, call for scientific costing studies

New Delhi, Oct. 28 -- Amid concerns over the high cost of healthcare in India, hospital and industry leaders have questioned whether government-determined treatment rates adequately reflect the cost o... और पढ़ें


Indian patent office rejects TB Alliance's patent for Drug-Resistant TB treatment

New Delhi, Oct. 28 -- The Indian Patent Office has rejected a patent application by the US-based Global Alliance for TB Drug Development (TB Alliance) for BPaL, a treatment for drug-resistant tubercul... और पढ़ें